Jagsonpal Historical Cash Flow
| JAGSNPHARM | 636.65 9.80 1.52% |
Analysis of Jagsonpal Pharmaceuticals cash flow over time is an excellent tool to project Jagsonpal Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 366.6 M or Change In Working Capital of 58.2 M as it is a great indicator of Jagsonpal Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Jagsonpal Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Jagsonpal Pharmaceuticals is a good buy for the upcoming year.
Jagsonpal |
About Jagsonpal Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Jagsonpal balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Jagsonpal's non-liquid assets can be easily converted into cash.
Jagsonpal Pharmaceuticals Cash Flow Chart
Add Fundamental
Change To Inventory
The increase or decrease in the amount of inventory a company has over a certain period.Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Depreciation
Depreciation indicates how much of Jagsonpal Pharmaceuticals value has been used up. For tax purposes Jagsonpal Pharmaceuticals can deduct the cost of the tangible assets it purchases as business expenses. However, Jagsonpal Pharmaceuticals Limited must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Capital Expenditures
Capital Expenditures are funds used by Jagsonpal Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Jagsonpal Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Jagsonpal Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Jagsonpal Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jagsonpal Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. As of now, Jagsonpal Pharmaceuticals' Change In Working Capital is increasing as compared to previous years. The Jagsonpal Pharmaceuticals' current Begin Period Cash Flow is estimated to increase to about 179.7 M, while Other Cashflows From Financing Activities is projected to decrease to (15.2 M).
Jagsonpal Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Jagsonpal Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Jagsonpal Pharmaceuticals cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 33.7M | (4.0M) | (176K) | 90.7M | 53.1M | 55.8M | |
| Change In Cash | (4.6M) | 191.3M | (329.1M) | (114.7M) | 17.1M | 17.9M | |
| Free Cash Flow | 91.8M | 277.5M | 51.3M | 463.4M | 349.2M | 366.6M | |
| Change In Working Capital | 42.5M | 115.9M | (171.3M) | 98.7M | 55.4M | 58.2M | |
| Begin Period Cash Flow | 385.3M | 398.1M | 589.4M | 225.3M | 110.5M | 179.7M | |
| Other Cashflows From Financing Activities | 3.7M | (5.1M) | (18.2M) | (3.2M) | (14.5M) | (15.2M) | |
| Depreciation | 11.3M | 10.9M | 15.3M | 12.1M | 16.6M | 15.0M | |
| Other Non Cash Items | (35.5M) | (63.3M) | (61.2M) | (2.4M) | (78.1M) | (74.2M) | |
| Capital Expenditures | 20.7M | 4.7M | 4.7M | 3.2M | 2.5M | 2.4M | |
| Total Cash From Operating Activities | 112.5M | 282.2M | 56.0M | 466.5M | 351.7M | 369.2M | |
| Net Income | 94.1M | 218.7M | 273.2M | 348.1M | 224.6M | 116.5M | |
| Total Cash From Financing Activities | (9.4M) | (68.3M) | (123.0M) | (4.6M) | (89.1M) | (93.6M) | |
| End Period Cash Flow | 380.7M | 589.4M | 260.3M | 110.5M | 127.6M | 184.2M | |
| Dividends Paid | 13.1M | 26.2M | 104.8M | 0.0 | 131.0M | 137.5M | |
| Change To Account Receivables | (7.0M) | 87.9M | (29.6M) | (55.6M) | 91.5M | 96.1M | |
| Net Borrowings | (45.2M) | 8.8M | (67.9M) | (3.2M) | (2.9M) | (3.0M) | |
| Total Cashflows From Investing Activities | (110.7M) | (22.6M) | (262.1M) | (576.7M) | (519.0M) | (493.1M) | |
| Change To Operating Activities | 27.3M | (57.9M) | (114.9M) | 83.3M | 75.0M | 78.7M | |
| Other Cashflows From Investing Activities | 21.7M | 23.8M | 27.1M | 34.3M | 73.7M | 77.4M | |
| Change To Netincome | (19.5M) | (15.2M) | 16.1M | 88.8M | 102.2M | 107.3M | |
| Change To Liabilities | (3.7M) | 182.9M | 8.8M | (19.6M) | (22.6M) | (21.4M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Jagsonpal Stock
The Cash Flow Statement is a financial statement that shows how changes in Jagsonpal balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Jagsonpal's non-liquid assets can be easily converted into cash.